Some of the most popular GLP-1 agonists available by prescription are Ozempic, Wegovy, Mounjaro, and Zepbound
Wegovy HD 7.2 mg, the recently approved higher-dose version of semaglutide, shows a similar dose-dependent increase, with dysesthesia reported in roughly 22% of people at that dose compared to about 6% at the standard 2.4 mg dose
The film coating protects the active ingredient and aids swallowing
While Eli Lillys current market capitalization remains supported by the success of Zepbound and Mounjaro, any delayed or restricted label expansion for retatrutide could compress current valuation multiples
Overdoses Fighting the nations overdose epidemic has long been a priority for both Republicans and Democrats
Thank You for your valuable time